98716 Geschwenda, de
+49 (36205) 98-111
Geratherm Medical AG successfully completes capital increase
Capital stock raised by 10 percent / Strong demand among national and international investors
As part of the accelerated book building process, all 450,000 new shares being offered were successfully placed with qualified institutional investors both in Germany and abroad at EUR 8.00 per share. The capital increase therefore generated gross proceeds of around EUR 3.6 million.
By broadening the equity capital base, the shareholder structure was substantially expanded in Germany and abroad. With equity capital in excess of 80%, the Company believes that its strong balance sheet ratios put it in an excellent position to sustain its buoyant growth track from 2009. The inflow of funds is primarily intended to go towards further innovative product developments and also be invested in inorganic growth.
The Company's capital stock will be EUR 4,950,000.00 after the capital increase has been entered into the commercial register. The new shares are being released for trading in the regulated market (Prime Standard) of the Frankfurt Stock Exchange without prospectus.
The capital increase, which was considerably oversubscribed by national and international investors, was supported by Close Brothers Seydler Bank AG, Frankfurt am Main as sole lead manager und sole bookrunner.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an firstname.lastname@example.org.